ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295499 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295499; 2) Community: the network communities that were significantly associated with the response to NSC 295499; 3) Molecule: the relationships between components within communities and NSC 295499; 4) MDR: the compounds that were significantly associated with the NSC 295499.

NSC Compound Enrichment Correlation
NSC 134723 K 31 0.0478540623811426 0.55856428
NSC 178248 Chlorozotocin 0.0478540623811426 0.69351825
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0478540623811426 0.17531504
NSC 354051 LISCUNDITRIN 0.0478540623811426 0.16410132
NSC 374980 Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- 0.0478540623811426 0.28585783
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.0478540623811426 0.37903349
NSC 38530 Null 0.0478540623811426 0.0090703018
NSC 48526 Null 0.0478540623811426 0.079619694
NSC 625603 Null 0.0478540623811426 0.31142553
NSC 629971 Camptothecin Derivative 0.0478540623811426 0.81989081
Total:50  Current:44    [First] [Prev] [Next] [Last]